Thomas Boerner

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma

Andrea Cercek, Thomas Boerner, Benjamin Tan et al. · JAMA Oncology · 2019 · 223 citations · Full text

Medicine, Oncology, Pharmacology +13

Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma

Thomas Boerner, Esther Drill, Linda M. Pak et al. · Hepatology · 2021 · 162 citations · Full text

Medicine, Genetics, Oncology +17

Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?

Johan Gagnière, Aurélien Dupré, Sepideh Gholami et al. · Annals of Surgery · 2018 · 102 citations

Medicine, Oncology, Surgery +17

Long-Term Oncologic Outcomes Following Robotic Liver Resections for Primary Hepatobiliary Malignancies: A Multicenter Study

Sidrah Khan, Rachel E. Beard, T. Peter Kingham et al. · Annals of Surgical Oncology · 2018 · 95 citations · Full text

Medicine, Oncology, Surgery +12